Simplex Trading’s ProShares UltraShort Health Care RXD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
14,700
-31,850
-68% -$587K ﹤0.01% 2442
2025
Q4
$3.28M Buy
46,550
+14,200
+44% +$279K ﹤0.01% 1589
2025
Q3
$2.11M Buy
32,350
+6,500
+25% +$157K ﹤0.01% 2271
2025
Q2
$1.75M Sell
25,850
-16,500
-39% -$403K ﹤0.01% 2233
2025
Q1
$2.76M Sell
42,350
-73,650
-63% -$1.59M ﹤0.01% 1738
2024
Q4
$8.42M Buy
116,000
+27,550
+31% +$585K ﹤0.01% 1142
2024
Q3
$4.56M Sell
88,450
-21,350
-19% -$419K ﹤0.01% 1559
2024
Q2
$6.13M Sell
109,800
-393,000
-78% -$8.62M ﹤0.01% 1306
2024
Q1
$12.1M Sell
502,800
-64,200
-11% -$1.4M 0.01% 1005
2023
Q4
$17.3M Buy
567,000
+47,500
+9% +$1.25M 0.01% 782
2023
Q3
$18.4M Sell
519,500
-131,950
-20% -$3.31M 0.01% 629
2023
Q2
$19.9M Sell
651,450
-209,900
-24% -$5.31M 0.02% 580
2023
Q1
$34.9M Sell
861,350
-139,850
-14% -$3.59M 0.03% 375
2022
Q4
$48.4M Sell
1,001,200
-145,800
-13% -$3.7M 0.05% 282
2022
Q3
$62.2M Buy
1,147,000
+251,350
+28% +$6.78M 0.07% 196
2022
Q2
$42.2M Sell
895,650
-220,450
-20% -$5.98M 0.04% 282
2022
Q1
$41.7M Sell
1,116,100
-51,700
-4% -$1.4M 0.04% 330
2021
Q4
$36.2M Buy
1,167,800
+257,850
+28% +$6.84M 0.04% 340
2021
Q3
$33.9M Buy
909,950
+136,350
+18% +$3.67M 0.03% 319
2021
Q2
$29.1M Buy
773,600
+768,631
+15,469% +$24.6M 0.03% 342
2021
Q1
$8.6M Buy
4,969
+251
+5% +$9.08K 0.02% 522
2020
Q4
$23.9M Sell
4,718
-1,140
-19% -$48.1K 0.03% 312
2020
Q3
$30.3M Buy
5,858
+2,197
+60% +$104K 0.04% 250
2020
Q2
$25.7M Buy
3,661
+1,828
+100% +$105K 0.04% 247
2020
Q1
$18.6M Sell
1,833
-272
-13% -$20K 0.03% 253
2019
Q4
$20.3M Buy
2,105
+631
+43% +$50K 0.04% 271
2019
Q3
$14.7M Buy
1,474
+410
+39% +$36.1K 0.04% 307
2019
Q2
$11.6M Buy
1,064
+114
+12% +$10.5K 0.03% 358
2019
Q1
$11.9M Sell
950
-945
-50% -$87.4K 0.03% 340
2018
Q4
$29.8M Buy
1,895
+172
+10% +$16.5K 0.09% 141
2018
Q3
$25M Sell
1,723
-59
-3% -$5.54K 0.08% 173
2018
Q2
$26.1M Buy
1,782
+1,071
+151% +$124K 0.1% 136
2018
Q1
$347K Sell
711
-504
-41% -$56.7K 0.02% 906
2017
Q4
$260K Sell
1,215
-5
-0.4% -$618 0.01% 1091
2017
Q3
$475K Buy
1,220
+32
+3% +$4.2K 0.02% 698
2017
Q2
$479K Sell
1,188
-877
-42% -$132K 0.02% 680
2017
Q1
$776K Buy
2,065
+418
+25% +$70K 0.03% 471
2016
Q4
$471K Buy
1,647
+263
+19% +$49K 0.03% 580
2016
Q3
$216K Sell
1,384
-13
-0.9% -$2.24K 0.01% 982
2016
Q2
$278K Buy
1,397
+239
+21% +$46K 0.02% 811
2016
Q1
$674K Sell
1,158
-30
-3% -$6.62K 0.05% 330
2015
Q4
$658K Buy
1,188
+87
+8% +$17.7K 0.05% 323
2015
Q3
$1.02M Buy
1,101
+677
+160% +$137K 0.07% 234
2015
Q2
$608K Buy
424
+338
+393% +$67.2K 0.05% 344
2015
Q1
$143K Buy
+86
New +$18.8K 0.02% 884

Other funds holding RXD

Simplex Trading's RXD Position: Q2 2025 in Review

Simplex Trading sold out of ProShares UltraShort Health Care (RXD) in Q2 2025, closing a stake of 81 shares — an estimated $1.98K sold.

Simplex Trading first reported a position in RXD in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2025. 4 funds tracked by Wall St. Rank hold RXD as of Q2 2025.

  • Simplex Trading reported no remaining ProShares UltraShort Health Care position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 81 ProShares UltraShort Health Care shares in Q2 2025, an estimated $1.98K.
  • Simplex Trading first reported a position in ProShares UltraShort Health Care in Q4 2022 and held it in 4 quarters.
  • Simplex Trading's ProShares UltraShort Health Care position peaked at $1K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.